» Articles » PMID: 37035655

CRISPR/Cas9 Establishment-mediated Targeted Mutagenesis in

Overview
Journal Front Physiol
Date 2023 Apr 10
PMID 37035655
Authors
Affiliations
Soon will be listed here.
Abstract

CRISPR/Cas9 is a gene-editing technology which could specifically cleave dsDNA and induce target gene mutation. CRISPR/Cas9 has been widely used in gene functional studies in many fields, such as medicine, biology, and agriculture due to its simple design, low cost, and high efficiency. Although it has been well developed in model fish and freshwater fish for gene function analysis, it is still novel in the studies dealing with economic crustacean species. In this study, we established a CRISPR/Cas9 system based on microinjection for , an important economic crustacean aquaculture species. The () gene and the () gene were selected as the targeted genes for mutation. Two sgRNAs were designed for and gene editing, respectively. For sg--1, the gastrula survival ratio was 8.69%, and the final hatching ratio was 4.83%. The blastula mutant ratio was 10%, and the hatching individual mutant ratio was 30%. For sg--2, the gastrula survival ratio was 5.85%, and the final hatching ratio was 3.89%. The blastula mutant ratio was 16.67%, and no mutant sequences were detected in hatching individuals. For sg--1, the gastrula survival ratio was 6.25%, and the final hatching ratio was 2.34%. The blastula mutant ratio was 10.00%, and the hatching individual mutant ratio was 66.67%. For sg--2, the gastrula survival ratio was 6.00%, and the final hatching ratio was 2.67%. No mutant sequence was detected in both blastula stage and hatching individuals. There were no significant morphological changes observed in the group. Two deformed types were detected in sg--1-injected embryos. An evident developmental delay of the compound eye was detected in sg1-H1 in the zoea stage. The compound eyes of the sg1-H2 embryo could not form well-defined spheres, and the whole compound eye appeared to diffuse at the end of the late zoea stage. The establishment of a gene-editing platform based on CRISPR/Cas9 will not only provide an efficient and convenient method for gene function analysis but also provide a powerful tool for molecular-assisted breeding of .

Citing Articles

Roadmap and Considerations for Genome Editing in a Non-Model Organism: Genetic Variations and Off-Target Profiling.

Wattad H, Molcho J, Manor R, Weil S, Aflalo E, Chalifa-Caspi V Int J Mol Sci. 2024; 25(23).

PMID: 39684244 PMC: 11641748. DOI: 10.3390/ijms252312530.

References
1.
Gui T, Zhang J, Song F, Sun Y, Xie S, Yu K . CRISPR/Cas9-Mediated Genome Editing and Mutagenesis of in . G3 (Bethesda). 2016; 6(11):3757-3764. PMC: 5100874. DOI: 10.1534/g3.116.034082. View

2.
Baek K, Kim D, Jeong J, Sim S, Melis A, Kim J . DNA-free two-gene knockout in Chlamydomonas reinhardtii via CRISPR-Cas9 ribonucleoproteins. Sci Rep. 2016; 6:30620. PMC: 4964356. DOI: 10.1038/srep30620. View

3.
Ansai S, Kinoshita M . Targeted mutagenesis using CRISPR/Cas system in medaka. Biol Open. 2014; 3(5):362-71. PMC: 4021358. DOI: 10.1242/bio.20148177. View

4.
Cui Z, Liu Y, Wang W, Wang Q, Zhang N, Lin F . Genome editing reveals dmrt1 as an essential male sex-determining gene in Chinese tongue sole (Cynoglossus semilaevis). Sci Rep. 2017; 7:42213. PMC: 5311979. DOI: 10.1038/srep42213. View

5.
Wang Y, Jin S, Fu H, Qiao H, Sun S, Zhang W . Identification and Characterization of the Gene in the Oriental River Prawn . Int J Mol Sci. 2019; 20(7). PMC: 6480115. DOI: 10.3390/ijms20071734. View